Publicaciones en colaboración con investigadoras/es de Hospital Universitario La Paz (16)

2023

  1. The Gluten-Free Diet for Celiac Disease: Critical Insights to Better Understand Clinical Outcomes

    Nutrients, Vol. 15, Núm. 18

2022

  1. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. Long runs of homozygosity are associated with Alzheimer’s disease

    Translational Psychiatry, Vol. 11, Núm. 1

2019

  1. Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project

    Alzheimer's and Dementia, Vol. 15, Núm. 10, pp. 1333-1347

2018

  1. CCR-CARESS score for predicting operative mortality in patients with colorectal cancer

    British Journal of Surgery, Vol. 105, Núm. 13, pp. 1853-1861

2016

  1. Colorectal cancer health services research study protocol: The CCR-CARESS observational prospective cohort project

    BMC Cancer, Vol. 16, Núm. 1

  2. Nab-Paclitaxel in metastatic breast cancer: Defining the best patient profile

    Current Cancer Drug Targets, Vol. 16, Núm. 5, pp. 415-428

2015

  1. MAPT H1 haplotype is associated with late-onset Alzheimer's disease risk in APOE ε 4 noncarriers: Results from the dementia genetics Spanish consortium

    Journal of Alzheimer's Disease, Vol. 49, Núm. 2, pp. 343-352

2014

  1. Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia

    Neurobiology of Aging, Vol. 35, Núm. 2, pp. 444.e1-444.e4

2013

  1. Fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus FAC followed by weekly paclitaxel as adjuvant therapy for high-risk, node-negative breast cancer: Results from the GEICAM/2003-02 study

    Journal of Clinical Oncology

2009

  1. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

    Nature Genetics, Vol. 41, Núm. 10, pp. 1094-1099

  2. Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma

    European Journal of Cancer, Vol. 45, Núm. 5, pp. 732-735

2000

  1. Alzheimer's risk associated with human apolipoprotein E, alpha-2 macroglobulin and lipoprotein receptor related protein polymorphisms: Absence of genetic interactions, and modulation by gender

    Neuroscience Letters, Vol. 289, Núm. 3, pp. 213-216

  2. Cholesterolemia control in Spain, 2000: A tool for cardiovascular disease prevention

    Revista Espanola de Cardiologia, Vol. 53, Núm. 6, pp. 815-837

  3. Cholesterolemia control in Spain, 2000: A tool for cardiovascular disease prevention

    Revista Clinica Espanola, Vol. 200, Núm. 9, pp. 494-515